Nevertheless, based on E-selectin’s important role and expression at the site of inflammation and infection, the main concern regarding targeting selectively and specifically E-selectin in the cancer tissue, and not in other inflammation sites, remains a challenge that needs to be addressed in future research. Here, SELE is linked to cancer.